Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
monosialoganglioside
DRUG
2 trials
Sponsors
Peking University Cancer Hospital & Institute
, Qilu Pharmaceutical Co., Ltd.
Conditions
Acute Ischemic Stroke
Neurotoxicity
Phase 2
Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients
NCT02500810
Peking University Cancer Hospital & Institute
Neurotoxicity
Start: 2015-07-31
End: 2018-12-31
Target: 106
Updated: 2015-07-17
Phase 3
Monosialoganglioside in Acute Ischemic Stroke: a Randomized, Blinded and Multicenter Confirmatory Study
Completed
NCT06742216
Qilu Pharmaceutical Co., Ltd.
Acute Ischemic Stroke
Start: 2020-11-03
End: 2023-08-30
Updated: 2024-12-19